Patch to Minimize the Effects of Parkinson
Parkinson’s is a neurological disease that is associated with muscle rigidity, difficulty walking, tremors and impaired movement coordination. Parkinson’s is a very common disease affecting 2 of every 1000 people, and further developed from the age of 50, equally to men and women.
Currently on the market a new drug that will prevent loss of efficacy and adverse consequences that come with conventional drugs after year. A single daily application provides a good control of Parkinson’s symptoms for a period of 24 hours.
With this system, the drug penetrates the skin of the patient reaches the brain and exerts its action in a consistent and sustained, mimicking the normal action of dopamine, the substance deficit in Parkinson’s patients. The patch, developed by Schwarz Pharma laboratories and is available in Spanish pharmacies under the name of Rotigotine Neupro and improve the quality of life of patients, among other things, thanks to its easy us